What to Watch

Where the case stands

Reconciled, the eight preceding chapters do not settle the through-line — whether the 2024–25 deceleration is a fixable stumble or a structural ceiling. They narrow it to four measurable outcomes over the next few quarters: the growth run-rate, the direction of absolute stock compensation, the shape of the Google ad-tech remedy, and whether management meets its own guidance again. The case is genuinely two-sided today; a short list of checkable lines will decide it.

This chapter does three things: it lays the five threads side by side as a bull-versus-bear tension table, it puts the price against three scenarios, and it names the falsifiable signposts — each tied to a specific line item, filing, and threshold — that would move the read one way or the other.

Reconciling the five threads

Each row below is a shared fact — a number or filing item both sides accept — followed by how the bull and bear read it, and the specific evidence that would settle it. The disagreement is rarely about the facts; it is about which way they resolve from here.

Sources: FY2025 revenue and Q1 2026 growth and Q2 guide, Q1 2026 earnings call [1]; international vs US growth, FY2025 Form 10-K [2]; cash flow and stock comp, FY2025 Form 10-K [3]; Google ruling, Q1 2025 earnings call [4]; voting power, 2026 proxy statement [5]. The reconciled reads draw on The Business, The Independence Moat, The Growth Engine, The Infrastructure Bet, Stock Comp and Cash, What the Price Implies, Control and Execution, and The Amazon Overlap.

The five rows are not independent. Rows 2 and 4 are the same disagreement viewed twice — the valuation read moves with the stock-comp read, because the reverse-DCF that reads "cheap" on reported free cash flow reads "roughly fair" once compensation is charged. Row 1 feeds row 4 as well: the base-case multiple assumes a steady low-double-digit grower, so a run-rate that settles below 10% pulls the whole valuation frame toward the bear column. The through-line therefore rests on a small, correlated set of variables, not five separate ones — which is what makes a signpost list workable rather than a wish for omniscience.

Three scenarios against the price

The valuation chapter (What the Price Implies) projected FY2025 revenue forward three years at different growth rates and exit multiples, discounted back at 10%. The result is a fair-value range whose base case sits within cents of the traded price — meaning the market is already paying for a steady grower at today's multiple, not for a recovery and not for a collapse.

Source: derived from reported financials, FY2025 Form 10-K — revenue and share count [6] and net cash [7]; scenario method per What the Price Implies.

The asymmetry is the point. The bear case at roughly $12.50 needs only that revenue grow 6% and the EV/Sales multiple compress from 2.9x to 2.0x — continuation of what is already happening, no new bad news required. The bull case near $28 needs both faster growth (14%) and multiple expansion (to 4.0x), a compound recovery. The base case near $19.60 assumes 10% growth at an unchanged 3.0x multiple. The range is more sensitive to the exit multiple — about $6 per share for each turn of EV/Sales — than to the growth rate, so a re-rating, up or down, moves the stock more than a beat or miss on revenue. The counterweight the bear column understates is the balance sheet: about $1.3 billion of net cash and no funded debt [8], funding buybacks that repurchased shares into the collapse.

The multiples' sensitivity to stock compensation

The split between "cheap" and "fairly priced" is most sensitive to one line item: stock-based compensation. It ran $490.6 million in FY2025 — 62% of reported free cash flow — and has held essentially flat near $490–495 million for three straight years [9]. A common bull argument is that this figure falls on its own as the 2021 CEO Performance Option finishes amortizing, converging the reported (~12x) and stock-comp-charged (~32x) free-cash multiples without any change in price. The composition data complicates that.

Source: total stock comp, FY2025 Form 10-K Statements of Cash Flows [10]; CEO Performance Option component [11]; core comp is the residual.

The CEO Performance Option expense fell from $198 million in 2023 to $128 million in 2024 to $67 million in 2025, and only $5 million of it remains unrecognized, expected to finish within about 0.2 years [12]. Yet total compensation did not fall, because core employee (non-option) SBC rose to fill the gap — from about $294 million to $424 million over the same two years. The pipeline behind that core figure is large: at the end of 2025 the company carried roughly $677 million of unrecognized restricted-stock compensation, to be recognized over a weighted-average 2.8 years [13]. The option roll-off is real, but it frees roughly $62 million a year into a rising core base of over $240 million a year in already-committed cost, plus new grants. Whether total stock comp actually declines in 2026 is therefore an open question the FY2026 10-K will answer directly — the figure the valuation is most sensitive to across the two columns of the tension table.

The signposts

The four watch items below are ranked by decision value — how much each would move the read on the through-line — with the specific line, the filing that reports it, and the threshold that would tilt the case bull or bear.

Sources: guidance and growth, Q1 2026 earnings call [14]; stock comp, FY2025 Form 10-K [15] and Note 10 [16]; Google ruling, Q1 2025 earnings call [17]; missed-guidance streak, Q4 2024 earnings call [18]. Next-quarter consensus and estimate revisions per consensus estimates as of July 2026.

Growth is the first and highest-value signpost. Management guided Q2 2026 revenue to at least $750 million, and consensus of about $752 million implies roughly 8% year-over-year growth against $694 million a year earlier [19]. Full-year consensus sits near $3.18 billion for 2026 and $3.48 billion for 2027 — about 9–10% each year, roughly half the 18.5% of 2025. The near-term risk skews to the downside: in the seven days before this reading, downward FY2026 earnings revisions outnumbered upward ones by roughly 18 to 2, and the Street's ratings are hold-weighted (2 strong buy, 11 buy, 19 hold, 4 sell) even with a mean target of $24.42 well above the $19.53 price. A print that holds growth in the low teens would reopen the cyclical read; a fifth straight step-down toward single digits would harden the structural one.

The base rate argues for caution on the print itself. The forecasting record that made The Trade Desk credible broke in Q4 2024 with a self-diagnosed 'our fault' miss, and the fix - the largest reorganization in company history - has yet to arrest a deceleration to 12% growth, so the case for reacceleration is a bet on management executing through a stumble it caused. For roughly four years The Trade Desk beat consensus almost every quarter, often by wide margins; that streak broke on both the internal metric — the first guidance miss in 33 quarters, self-diagnosed as "it was our fault" [20] — and the external one: Q1 2026 adjusted earnings came in about 12% below consensus. The habit of clearing a lowered bar, which underwrote the old multiple, can no longer be assumed; that is precisely why the next few prints carry more weight than usual.

The Google remedy is the widest-variance signpost and the one least in management's hands. Green frames the illegal-monopoly rulings as validation of the open-internet thesis, while noting the changes "impact the buy-side less than the sell-side" [21]. That candor cuts both ways: a structural remedy that forces a divestiture of Google's exchange most directly benefits supply-side platforms, and reaches The Trade Desk only second-hand through a fairer, more competitive supply chain. It is a real tailwind with an uncertain magnitude and a slow, appeal-laden timetable — upside optionality to the through-line, not a near-term catalyst to underwrite.

What would change the read

The evidence today does not decide the through-line, and the honest position is to say so and name the tests rather than force a winner. The read that best fits the current facts is a company decelerating faster than the bulls hoped but not yet demonstrably capped — priced, on charged cash flow, roughly fairly for what it has become, with a net-cash balance sheet and disciplined buybacks providing a floor the bear case tends to skip. The strongest fact against that read is the run-rate itself: five consecutive quarterly step-downs, concentrated in the large US core, are not what a purely cyclical wobble usually looks like.

Two outcomes would move it decisively. Growth stabilizing in the low teens for two or three quarters, with total stock compensation finally declining as the option roll-off outpaces core grants, would validate the cyclical read and converge the two free-cash multiples on their own — the bull column. A run-rate settling below 10% while core compensation keeps the reported and charged multiples apart, against an unsettled bench and a second self-inflicted miss, would confirm a lower structural plateau — the bear column. Both are visible in filings already scheduled, on line items named above. For a business this cash-generative and this cheap on reported numbers, the resolution is unusually near-term and unusually checkable.